|
|
|
Volumn 16, Issue 7, 1994, Pages 525-537
|
|
Gene technology: Chances for diagnosis and therapy
|
|
Author keywords
Antisense blocker; Clinical considerations; Economy; Ethics; Gene therapy; Hybridization technology; Monoclonal antibodies; Substitution therapy; Tumor imaging; Vaccines
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
MONOCLONAL ANTIBODY;
RECOMBINANT DNA;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
UNINDEXED DRUG;
VACCINE;
BIOTECHNOLOGY;
CONFERENCE PAPER;
CONGENITAL DISORDER;
ECONOMICS;
ETHICS;
GENE TECHNOLOGY;
GENETIC DISORDER;
HUMAN;
HYBRIDIZATION;
RECOMBINANT DNA TECHNOLOGY;
BIOPHARMACEUTICS;
BIOTECHNOLOGY;
CLINICAL TRIALS;
FEMALE;
GENE THERAPY;
HUMAN;
NUCLEIC ACID HYBRIDIZATION;
OLIGONUCLEOTIDES, ANTISENSE;
PREGNANCY;
PRENATAL DIAGNOSIS;
|
|
EID: 0028153161
PISSN: 03790355
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
